Par Drugs And Chemicals Limited

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹104.93
Market cap
129 Cr
Stock P/E
9.3
P/B
1.21

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2025Jun 2025Sept 2025Dec 2025
Sales22 Cr26 Cr29 Cr29 Cr
Operating expenses (approx.)19 Cr21 Cr22 Cr22 Cr
EBITDA3 Cr5 Cr7 Cr7 Cr
OPM %14.4%20.7%22.8%25.2%
Other income0.79 Cr2 Cr0.48 Cr1 Cr
Interest0.02 Cr0.02 Cr0.05 Cr0.01 Cr
Depreciation0.92 Cr0.90 Cr0.94 Cr0.93 Cr
Profit before tax2 Cr4 Cr6 Cr6 Cr
Tax %27.5%25.7%25.6%25.5%
Net profit2 Cr3 Cr4 Cr5 Cr
EPS (₹)₹1.34₹2.70₹3.36₹3.90

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2025TTM
Sales101 CrSign in for TTM
Operating expenses (approx.)79 CrSign in for TTM
EBITDA22 CrSign in for TTM
OPM %21.4%Sign in for TTM
Other income2 CrSign in for TTM
Interest0.08 CrSign in for TTM
Depreciation4 CrSign in for TTM
Profit before tax18 CrSign in for TTM
Tax %25.5%Sign in for TTM
Net profit13 CrSign in for TTM
EPS (₹)₹10.86Sign in for TTM
Dividend payout %0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2025
Equity capital12 Cr
Reserves87 Cr
Borrowings
Other liabilities20 Cr
Total liabilities119 Cr
Fixed assets (net)39 Cr
CWIP0.0000 Cr
Investments25 Cr
Other assets55 Cr
Total assets119 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2025
Cash from operating activity16 Cr
Cash from investing-25 Cr
Cash from financing0.0000 Cr
Net cash flow-9 Cr
Free cash flow (OCF − Capex)15 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2025
ROCE %18.2%
ROE %13.5%
Debtor days
Inventory days56
Days payable
Cash conversion cycle56
Debt / equity0.00
Current ratio3.31
Net debt / EBITDA-1.27